Pharmaprocess
Pharmaprocess, headquartered in Sweden, is a leading player in the pharmaceutical and biotechnology industry, specialising in process development and manufacturing solutions. Founded in 2005, the company has established a strong presence across Europe, particularly in the Nordic region, and has achieved significant milestones in delivering innovative services tailored to the needs of its clients. Pharmaprocess offers a range of core services, including contract manufacturing, process optimisation, and regulatory support, distinguished by their commitment to quality and compliance. Their expertise in advanced bioprocessing techniques sets them apart in a competitive market, enabling them to cater to both small-scale and large-scale production needs. With a reputation for excellence, Pharmaprocess continues to solidify its position as a trusted partner for pharmaceutical companies seeking reliable and efficient solutions.
DitchCarbon Score
How does Pharmaprocess's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaprocess's score of 6 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaprocess's reported carbon emissions
Pharmaprocess, headquartered in Sweden (SE), currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Pharmaprocess may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it will be essential for Pharmaprocess to establish clear emissions data and reduction commitments to align with global climate goals and enhance its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaprocess is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
